nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivity
|
Becker, Alexandra A. |
|
2012 |
135 |
1 |
p. 167-175 |
artikel |
2 |
Are viruses associated with human breast cancer? Scrutinizing the molecular evidence
|
Joshi, Deepti |
|
2012 |
135 |
1 |
p. 1-15 |
artikel |
3 |
Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival
|
Jain, Sumit |
|
2012 |
135 |
1 |
p. 103-114 |
artikel |
4 |
BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients
|
Cerne, Jasmina Z. |
|
2012 |
135 |
1 |
p. 135-143 |
artikel |
5 |
Breast fat and breast cancer
|
Pettersson, Andreas |
|
2012 |
135 |
1 |
p. 321-323 |
artikel |
6 |
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
|
Wu, Lian-Ming |
|
2012 |
135 |
1 |
p. 17-28 |
artikel |
7 |
Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology
|
Ancukiewicz, Marek |
|
2012 |
135 |
1 |
p. 145-152 |
artikel |
8 |
Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer
|
Noordermeer, Sylvie M. |
|
2012 |
135 |
1 |
p. 125-133 |
artikel |
9 |
Feature extraction via composite scoring and voting in breast cancer
|
Koch, Martin |
|
2012 |
135 |
1 |
p. 307-318 |
artikel |
10 |
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression
|
Vargas, Ana Cristina |
|
2012 |
135 |
1 |
p. 153-165 |
artikel |
11 |
High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers
|
Chew, G. L. |
|
2012 |
135 |
1 |
p. 177-187 |
artikel |
12 |
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences
|
Kwast, Annemiek B. G. |
|
2012 |
135 |
1 |
p. 271-280 |
artikel |
13 |
Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation
|
Wen, Yong Hannah |
|
2012 |
135 |
1 |
p. 93-102 |
artikel |
14 |
Impact of comorbidity on management and mortality in women diagnosed with breast cancer
|
Berglund, Anders |
|
2012 |
135 |
1 |
p. 281-289 |
artikel |
15 |
111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer
|
Fasih, Aisha |
|
2012 |
135 |
1 |
p. 189-200 |
artikel |
16 |
Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors
|
Chun, Yong Soon |
|
2012 |
135 |
1 |
p. 201-208 |
artikel |
17 |
Intraoperative ultrasound guidance for excision of non-palpable invasive breast cancer: a hospital-based series and an overview of the literature
|
Barentsz, M. W. |
|
2012 |
135 |
1 |
p. 209-219 |
artikel |
18 |
Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression
|
Pang, Judy |
|
2012 |
135 |
1 |
p. 59-66 |
artikel |
19 |
Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A
|
Sperk, Elena |
|
2012 |
135 |
1 |
p. 253-260 |
artikel |
20 |
Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy
|
Koolen, Bas B. |
|
2012 |
135 |
1 |
p. 231-240 |
artikel |
21 |
MRI in residual tumor size measurement in patient with breast cancer receiving neoadjuvant chemotherapy calls for caution
|
Wu, Lian-Ming |
|
2012 |
135 |
1 |
p. 319-320 |
artikel |
22 |
NFκB signaling is important for growth of antiestrogen resistant breast cancer cells
|
Yde, Christina W. |
|
2012 |
135 |
1 |
p. 67-78 |
artikel |
23 |
Nuclear nano-morphology markers of histologically normal cells detect the “field effect” of breast cancer
|
Bista, Rajan K. |
|
2012 |
135 |
1 |
p. 115-124 |
artikel |
24 |
Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification
|
Kornegoor, Robert |
|
2012 |
135 |
1 |
p. 49-58 |
artikel |
25 |
PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer
|
Prat, A. |
|
2012 |
135 |
1 |
p. 301-306 |
artikel |
26 |
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
|
Boer, Richard H. De |
|
2012 |
135 |
1 |
p. 241-252 |
artikel |
27 |
Predicting two-year quality of life after breast cancer surgery using artificial neural network and linear regression models
|
Shi, Hon-Yi |
|
2012 |
135 |
1 |
p. 221-229 |
artikel |
28 |
Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program
|
Hofvind, Solveig |
|
2012 |
135 |
1 |
p. 291-299 |
artikel |
29 |
Statin use and risk of breast cancer: a meta-analysis of observational studies
|
Undela, Krishna |
|
2012 |
135 |
1 |
p. 261-269 |
artikel |
30 |
Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers
|
Nahta, Rita |
|
2012 |
135 |
1 |
p. 39-48 |
artikel |
31 |
Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma
|
Jabbour, Mark N. |
|
2012 |
135 |
1 |
p. 29-37 |
artikel |
32 |
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor
|
Iorns, Elizabeth |
|
2012 |
135 |
1 |
p. 79-91 |
artikel |